Cemiplimab
R2810-ONC-1676
Phase 3 small_molecule completed
Quick answer
Cemiplimab for Squamous Cell Carcinoma (SCC) is a Phase 3 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Squamous Cell Carcinoma (SCC)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed